文献速递眼底病与葡萄膜炎青光眼角膜与眼表疾病

SARS-CoV-2感染急性期后遗症与眼科疾病的双国队列研究

Postacute sequelae of SARS-CoV-2 infection on ophthalmic diseases: a binational cohort study.
PubMed 文献 · Br J Ophthalmol · 2026-05-18

该双国、基于人群的队列研究纳入韩国发现队列与日本验证队列中≥20岁SARS-CoV-2感染者,采用倾向评分重叠加权Cox模型评估急性期后眼科疾病风险。结果显示感染与任何眼科疾病长期风险升高相关(HR 1.23,95%CI 1.22-1.25),多种眼科疾病风险均升高,且随时间逐渐减弱、在重症COVID-19者中更明显,验证队列结果一致。

要点

  • SARS-CoV-2感染与任何眼科疾病长期风险升高相关,HR为1.23(95%CI 1.22-1.25)。
  • 青光眼、角膜结膜病、睑缘炎、视网膜病、葡萄膜炎及神经眼科疾病风险均升高。
  • 风险随时间逐渐减弱,重症COVID-19者更明显,不同变异时期结果基本一致。

核心结论

  • SARS-CoV-2感染后急性期眼科后遗症风险升高,需对多种眼科疾病保持持续临床警惕。

研究设计与样本

  • 双国、基于人群的队列研究,韩国为发现队列(n=15,992,761),日本为验证队列(n=12,218,680),纳入≥20岁SARS-CoV-2感染者,采用倾向评分重叠加权Cox比例风险模型估计HR,并按COVID-19严重程度和变异时期分层分析。

主要发现

  • SARS-CoV-2感染与任何眼科疾病长期风险升高相关,HR为1.23(95%CI 1.22-1.25)。
  • 青光眼HR为1.21(95%CI 1.19-1.23),角膜和结膜疾病HR为1.22(95%CI 1.21-1.23),睑缘炎HR为1.19(95%CI 1.17-1.22)。
  • 视网膜病HR为1.17(95%CI 1.15-1.18),葡萄膜炎HR为1.11(95%CI 1.01-1.22),神经眼科疾病HR为1.11(95%CI 1.06-1.15)。
  • 感染后眼科疾病风险随时间逐渐减弱,重症COVID-19者风险更明显。
  • pre-Delta、Delta和Omicron时期关联基本一致,验证队列观察到相似模式。

临床怎么用

  • 对SARS-CoV-2感染后患者,尤其重症者,应关注青光眼、角膜结膜病、睑缘炎、视网膜病、葡萄膜炎及神经眼科疾病的长期筛查与随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic sequelae is limited. We conducted a binational, population-based cohort study to evaluate the association between postacute sequelae of SARS-CoV-2 infection and the risk of multiple ophthalmic diseases. METHODS: Data were collected from two large cohorts: South Korea (discovery cohort; n=15,992,761) and Japan (validation cohort; n=12,218,680), including individuals aged ≥20 years who were infected with SARS-CoV-2. Cox proportional hazards models with propensity score-based overlap weighting were used to estimate HRs, with analyses stratified by COVID-19 severity and SARS-CoV-2 variant period. RESULTS: In the overlap-weighted discovery cohort, 4 041 250 individuals (mean age 52.52 years (SD 11.52); 59.1% male) were included. SARS-CoV-2 infection was associated with a long-term increased risk of any ophthalmic disease (HR, 1.23 (95% CI, 1.22-1.25)). Elevated risks were observed for glaucoma (1.21 (1.19-1.23)), cornea and conjunctiva diseases (1.22 (1.21-1.23)), blepharitis (1.19 (1.17-1.22)), retinopathy (1.17 (1.15-1.18)), uveitis (1.11 (1.01-1.22)) and neuro-ophthalmic diseases (1.11 (1.06-1.15)). The risk of ophthalmic diseases gradually attenuated over time after SARS-CoV-2 infection. The risk was more pronounced among individuals with severe COVID-19. The associations between SARS-CoV-2 infection and the risk of ophthalmic diseases were generally consistent across the pre-Delta, Delta and Omicron eras. Similar patterns were consistently observed in the validation cohort. CONCLUSIONS: Our findings suggest an increased risk of postacute ophthalmic sequelae following SARS-CoV-2 infection, underscoring the need for sustained clinical vigilance across a broad range of ophthalmic conditions.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yang JM, Lee H, Park J, et al. Postacute sequelae of SARS-CoV-2 infection on ophthalmic diseases: a binational cohort study. Br J Ophthalmol. 2026. PMID: 42150854. doi:10.1136/bjo-2025-328412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。